Coronavirus (COVID-19) Update
AmerisourceBergen and our global businesses are highly engaged during the ongoing spread of the novel COVID-19 “Coronavirus."
Read our latest update

US Bioservices Dispensing Newly Approved ALECENSA

January 30, 2016

The U.S. Food and Drug Administration recently approved Genentech's ALECENSA (alectinib) to treat people with advanced (metastatic) ALK-positive non-small cell lunch cancer (NSCLC) whose disease has worsened.